Hyperbilirubinemia Clinical Trials

11 recruitingLast updated: June 18, 2026

There are 11 actively recruiting hyperbilirubinemia clinical trials across 10 countries. Studies span Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 4. Top locations include Bahawalpur, Punjab Province, Pakistan, Blantyre, Malawi, Cairo, Cairo Governorate, Egypt. Updated daily from ClinicalTrials.gov.


Hyperbilirubinemia Trials at a Glance

11 actively recruiting trials for hyperbilirubinemia are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Bahawalpur, Blantyre, and Cairo. Lead sponsors running hyperbilirubinemia studies include Amira Adel Fouly, Chinese University of Hong Kong, and Air Force Military Medical University, China.

Browse hyperbilirubinemia trials by phase

Treatments under study

About Hyperbilirubinemia Clinical Trials

Looking for clinical trials for Hyperbilirubinemia? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperbilirubinemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperbilirubinemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

The Efficacy of Ursodeoxycholic Acid (UDCA) as Adjuvant Therapy to Phototherapy in the Management of Neonatal Indirect Hyperbilirubinemia

Hyperbilirubinemia, Neonatal Indirect
Tishreen University Hospital70 enrolled1 locationNCT07110987
Recruiting
Phase 4

Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Neonatal hyperbilirubinemia
Amira Adel Fouly80 enrolled1 locationNCT06517862
Recruiting
Early Phase 1

Modified Diagnosis and Treatment of Neonatal Hemolysis With ETCOc in sNH

Neonatal hyperbilirubinemia
Women's Hospital School Of Medicine Zhejiang University250 enrolled1 locationNCT06832800
Recruiting
Not Applicable

Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management

Neonatal hyperbilirubinemia
The Fourth Affiliated Hospital of Zhejiang University School of Medicine100 enrolled1 locationNCT07346976
Recruiting
Phase 2Phase 3

Newborn Jaundice - An Investigation of Different Approaches to Light Therapy

Neonatal hyperbilirubinemia
Regionshospital Nordjylland116 enrolled2 locationsNCT06702241
Recruiting
Phase 2

COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

NeonatalIndirect Hyperbilirubinemia
Quaid-e-Azam Medical College110 enrolled1 locationNCT07102836
Recruiting
Not Applicable

Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn

Neonatal hyperbilirubinemiaHemolytic Disease of Newborn
Ministry of Health, Saudi Arabia84 enrolled1 locationNCT04218318
Recruiting

Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings

Hyperbilirubinemia, NeonatalJaundice, Neonatal
William Marsh Rice University1,000 enrolled3 locationsNCT03866213
Recruiting
Phase 2

Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice

MicrotiaPregnancy RelatedNeonatal Jaundice+1 more
Chinese University of Hong Kong94 enrolled1 locationNCT06087874
Recruiting

A Prospective Study: Smart Phone Application for Measure Serum Bilirubin Through Sclera Images

Deep LearningJaundiceHyperbilirubinemia+1 more
Air Force Military Medical University, China270 enrolled1 locationNCT06421844
Recruiting
Not Applicable

Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana

Neonatal hyperbilirubinemiaNeonatal Jaundice
Hillerod Hospital, Denmark150 enrolled1 locationNCT06399146